Syndecan-1 (CD138) Modulates Triple-Negative Breast Cancer Stem Cell Properties via Regulation of LRP-6 and IL-6-Mediated STAT3 Signaling.
Saved in:
| Title: | Syndecan-1 (CD138) Modulates Triple-Negative Breast Cancer Stem Cell Properties via Regulation of LRP-6 and IL-6-Mediated STAT3 Signaling. |
|---|---|
| Authors: | Ibrahim, Sherif A.1,2, Hassan, Hebatallah1,2, Vilardo, Laura3, Kumar, Sampath Katakam1, Kumar, Archana Vijaya1, Kelsch, Reinhard4, Schneider, Cornelia1, Kiesel, Ludwig1, Eich, Hans Theodor5, Zucchi, Ileana3, Reinbold, Rolland3, Greve, Burkhard5 greveb@uni-muenster.de, Götte, Martin1 mgotte@uni-muenster.de |
| Source: | PLoS ONE. Dec2013, Vol. 8 Issue 12, p1-1. 1p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
